Sorry in advance, @jaygatsby, this may offend you, but I'm...

Sorry in advance, @jaygatsby, this may offend you, but I'm attempting to presenting a different tone of thread from the sale and general doom and gloom.  As it turns out the company has quite a few things happening, but I doubt you're across them.  Just bringing some things up that you may want to research instead of posting mundane drivel.  

One thing (from memory) to think about is we signed a long-term supply arrangement with Ellume in October last year.  This was to be used on their quantum dot technology across the suite of their pipeline products to include influenza, strep, chlamydia, and another I can't think of the name of right now.

If you're interested in being involved in the trials  (flu and strep are happening now) you can go here: http://www.usc.edu.au/connect/business-and-industry/usc-clinical-trials-centre/trials/flu-study
http://www.usc.edu.au/connect/busin...e/trials/clinical-study-for-strep-a-detection

Anywho, back to your regularly scheduled bs.  I know you don't care, just show you the money.  Go ahead and spam the board now with 20 posts where one will do.


All IMHO, FWIW, DYOR, TDKA, blah blah blah....